Literature DB >> 18682876

Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study.

Michael F Fialkow1, Katherine M Newton, Noel S Weiss.   

Abstract

We conducted this study to estimate the rate of, and identify risk factors for, recurrent pelvic organ prolapse (POP) following primary surgical repair. The study consisted of a retrospective cohort study of 142 women who underwent primary surgical management of POP in 1993 and were followed up to 10 years. Prolapse severity was graded using an established classification system of clinical descriptors. Hazard ratios (HR) for recurrent POP were determined using Cox regression. 36 recurrent cases were identified (recurrence rate: 3.7 per 100 woman-years). A cystocele was the most frequent element of primary (87%) and recurrent (72%) prolapse. No predictors of the likelihood of recurrence were identified, though recurrence was somewhat more common among women with a history of two or fewer vaginal deliveries vs three or more (HR = 1.6; 95% confidence interval = 0.81-3.3). Recurrent POP following surgical management is common. Our ability to predict recurrence is limited.

Entities:  

Mesh:

Year:  2008        PMID: 18682876     DOI: 10.1007/s00192-008-0678-8

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  8 in total

1.  Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence.

Authors:  Amanda L Clark; Thomas Gregory; Virginia J Smith; Renee Edwards
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

2.  Procedures for pelvic organ prolapse in the United States, 1979-1997.

Authors:  Sarah Hamilton Boyles; Anne M Weber; Leslie Meyn
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

3.  Risk factors for prolapse recurrence after vaginal repair.

Authors:  James L Whiteside; Anne M Weber; Leslie A Meyn; Mark D Walters
Journal:  Am J Obstet Gynecol       Date:  2004-11       Impact factor: 8.661

4.  Levator contraction strength and genital hiatus as risk factors for recurrent pelvic organ prolapse.

Authors:  Babak Vakili; Yong T Zheng; Holly Loesch; Karolynn T Echols; Nicholas Franco; Ralph R Chesson
Journal:  Am J Obstet Gynecol       Date:  2005-05       Impact factor: 8.661

5.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

6.  Pelvic organ prolapse in older women: prevalence and risk factors.

Authors:  Ingrid Nygaard; Catherine Bradley; Debra Brandt
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

7.  Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women.

Authors:  Victoria L Handa; Elizabeth Garrett; Susan Hendrix; Ellen Gold; John Robbins
Journal:  Am J Obstet Gynecol       Date:  2004-01       Impact factor: 8.661

8.  Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity.

Authors:  Susan L Hendrix; Amanda Clark; Ingrid Nygaard; Aaron Aragaki; Vanessa Barnabei; Anne McTiernan
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661

  8 in total
  31 in total

1.  Structural position of the posterior vagina and pelvic floor in women with and without posterior vaginal prolapse.

Authors:  Christina Lewicky-Gaupp; Aisha Yousuf; Kindra A Larson; Dee E Fenner; John O L Delancey
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  Reoperation for pelvic organ prolapse within 10 years of primary surgery for prolapse.

Authors:  Philipp T Gotthart; Thomas Aigmueller; Peter F J Lang; George Ralph; Vesna Bjelic-Radisic; Karl Tamussino
Journal:  Int Urogynecol J       Date:  2012-04-27       Impact factor: 2.894

3.  Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse.

Authors:  Zeelha Abdool; Ranee Thakar; Abdul H Sultan; Reeba S Oliver
Journal:  Int Urogynecol J       Date:  2010-12-16       Impact factor: 2.894

4.  Efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12-month follow-up.

Authors:  Adi Y Weintraub; Menahem Neuman; Yonatan Reuven; Joerg Neymeyer; Naama Marcus-Braun
Journal:  World J Urol       Date:  2016-02-23       Impact factor: 4.226

5.  Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse.

Authors:  Patrick Dällenbach; Carol Jungo Nancoz; Isabelle Eperon; Jean-Bernard Dubuisson; Michel Boulvain
Journal:  Int Urogynecol J       Date:  2011-06-23       Impact factor: 2.894

6.  Preoperative quality of life questionnaires are an adequate tool to select women with genital prolapse for laparoscopic sacrocolpopexy.

Authors:  Enora Laas; Mattieu Haddad; Joël Muhlstein; Sofiane Bendifallah; Marcos Ballester; Emile Darai
Journal:  Int Urogynecol J       Date:  2017-07-19       Impact factor: 2.894

7.  Surgical outcomes of anterior trans-obturator mesh and vaginal sacrospinous ligament fixation for severe pelvic organ prolapse in overweight and obese Asian women.

Authors:  Tsia-Shu Lo; Yiap Loong Tan; Siwatchaya Khanuengkitkong; Anil Krishna Dass
Journal:  Int Urogynecol J       Date:  2012-10-24       Impact factor: 2.894

8.  The natural history of cystocele recurrence.

Authors:  H P Dietz; K J Hankins; V Wong
Journal:  Int Urogynecol J       Date:  2014-02-21       Impact factor: 2.894

9.  A randomized controlled trial comparing anatomical and functional outcome between vaginal colposuspension and transvaginal mesh.

Authors:  G Lamblin; A Van-Nieuwenhuyse; P Chabert; K Lebail-Carval; S Moret; G Mellier
Journal:  Int Urogynecol J       Date:  2014-02-27       Impact factor: 2.894

10.  Self-reported natural history of recurrent prolapse among women presenting to a tertiary care center.

Authors:  Payton Johnson; Kindra A Larson; Yvonne Hsu; Dee E Fenner; Daniel Morgan; John O L Delancey
Journal:  Int J Gynaecol Obstet       Date:  2012-10-14       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.